August 3, 2020

Volume X, Number 216

August 03, 2020

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
25
Jul
Trump Administration Releases Series of Executive Orders on Drug Pricing Mintz
24
Jul
Sixth Circuit Panel Dismisses Motion to Enforce Writ of Mandamus Squire Patton Boggs (US) LLP
24
Jul
No “White” Lie: Plaintiffs Fail to Show Reasonable Consumer Would Expect “White Morsels” to Contain White Chocolate Proskauer Rose LLP
24
Jul
Can Percentages be Rounded in Relative Nutrient Content Claims? Keller and Heckman LLP
24
Jul
FDA Issues Final Compliance Policy Guide on the Use of The Seafood List to Determine Acceptable Seafood Names Keller and Heckman LLP
23
Jul
COVID-19: FDA Clears Path for Test to Screen Asymptomatic Individuals Foley & Lardner LLP
23
Jul
FDA Announces Qualified Health Claim for Certain Cranberry Products and Urinary Tract Infections Keller and Heckman LLP
23
Jul
A Legen-dairy Victory: Ben & Jerry’s Wins “Happy Cows” False Advertising Lawsuit Proskauer Rose LLP
23
Jul
K&L Gates Triage: Recent Developments in the 340B Drug Pricing Program [Podcast] K&L Gates
22
Jul
Ohio Case Will Likely Determine Whether Other States Use 21st Amendment Enforcement Act McDermott Will & Emery
22
Jul
New FDA Draft Guidance Clarifies Cannabis-Related Clinical Research Requirements Keller and Heckman LLP
21
Jul
Senators Announce Bipartisan Bill Requiring Pharmaceutical Supply Chain Report Squire Patton Boggs (US) LLP
21
Jul
340b Update: HRSA Indicates It Lacks Authority to Enforce 340b Program Guidance K&L Gates
21
Jul
Elmiron Litigation Continues: What they still aren’t telling you… Stark & Stark
21
Jul
FDA Adds Five New Substances to its Inventory of Effective FCS Notifications 2020 Keller and Heckman LLP
21
Jul
FTC PrivacyCon 2020: Health Apps Area of FTC Focus Going Forward Squire Patton Boggs (US) LLP
21
Jul
Colombia Proposes New Chemical Regulatory Framework, Comments Due July 31, 2020 Beveridge & Diamond PC
21
Jul
Further Update on FDA’s Comprehensive Regenerative Medicine Framework: November 2020 Deadline Extended by Six Months Mintz
21
Jul
FDA Announces that Inspections of Small Businesses to Verify Compliance with the Intentional Adulteration Rule Will Begin March 2021 Keller and Heckman LLP
20
Jul
California Adopts Definition of Microplastics in Drinking Water Beveridge & Diamond PC

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS